Circulating Salivary miRNA hsa-miR-221 as Clinically Validated Diagnostic Marker for Hand, Foot, and Mouth Disease in Pediatric Patients

Documenti analoghi

• Circulating Salivary miRNA hsa-miR-221 as Clinically Validated Diagnostic Marker for Hand, Foot, and Mouth Disease in Pediatric Patients
  di: Min, Nyo, et al.
  Pubblicazione: (2018)
• Cytokine and Chemokine Profiling in Patients with Hand, Foot and Mouth Disease in Singapore and Malaysia
  di: Teo, Fiona Mei Shan, et al.
  Pubblicazione: (2018)
• Oncogenic role of miRNA-221/222 in breast cancer
  di: I Wayan Ardyan Sudharta Putra, et al.
  Pubblicazione: (2018-05-01)
• miRNA-221 and miRNA-222 synergistically function to promote vascular calcification
  di: Mackenzie, N C W, et al.
  Pubblicazione: (2014)
• Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer
  di: Lopes, Camile B., et al.
  Pubblicazione: (2018)